Axonics® CEO Raymond W. Cohen Receives Lifetime Entrepreneurial Achievement Award by the Southern California Biomedical CouncilBusiness Wire • 11/30/21
Axonics® Ranked the Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™Business Wire • 11/17/21
Axonics, Inc. (AXNX) CEO Raymond Cohen on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/07/21
Axonics Modulation Technologies (AXNX) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 11/04/21
U.S. Patent and Trademark Office Rejects Axonics' Challenge to Medtronic PatentsPRNewsWire • 09/13/21
Axonics, Inc.'s (AXNX) CEO Raymond Cohen on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/08/21
Axonics® Announces Appointment of Dr. Esteban López to its Board of DirectorsBusiness Wire • 07/15/21
Axonics® Files PMA Supplement with the FDA for Non-Rechargeable Implantable Sacral NeurostimulatorBusiness Wire • 06/24/21
Axonics® Announces CE Mark Approval for Implantable Sacral Neurostimulator that Significantly Extends Recharge IntervalBusiness Wire • 05/18/21
Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriters' Option to Purchase Additional StockBusiness Wire • 05/14/21
Axonics' (AXNX) CEO Raymond Cohen on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/09/21